Page 7,031«..1020..7,0307,0317,0327,033..7,0407,050..»

Comprehensive Care Corporation Receives Rate Increase on Pharmacy At-Risk Program for Key Client

Posted: Published on March 8th, 2012

TAMPA, Fla., March 8, 2012 /PRNewswire/ -- Comprehensive Care Corporation (CompCare) (OTC BB: CHCR), which provides behavioral health, substance abuse and at-risk psychotropic pharmacy management services for managed care companies throughout the U.S. and Puerto Rico, is pleased to announce that it has signed an amendment to its existing at-risk pharmacy management agreement with a major client serving Medicare members. CompCare received an 11% rate increase which equates to an annual increase of no less than $3.7 million based on our client's current membership. The rate increase has an effective date of January 1, 2012. "The rate increase, along with other initiatives being taken by the Company, results in our Puerto Rico subsidiary achieving immediate profitability starting January 1, 2012," said Clark A. Marcus, CompCare's Chairman and CEO. Additionally, the client extended the initial two-year term of the contract by an additional three months to December 31, 2012. About CompCare: Established in 1969, CompCare provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the United States. Headquartered in Tampa, Florida, CompCare focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches to behavioral health that address both the specific needs of … Continue reading

Posted in Pharmacy | Comments Off on Comprehensive Care Corporation Receives Rate Increase on Pharmacy At-Risk Program for Key Client

Navarro Discount Pharmacy opens in Pembroke Pines

Posted: Published on March 8th, 2012

Pembroke Pines residents stood in line in the rain this morning while they waited for the new Navarro Discount Pharmacy store to open in the Westfork Plaza. The new 16,000-square-foot store, located at 15825 Pines Blvd., is the companys first location to open in Broward County since the closure of a previous store more than three years ago. They have products that Walgreens and CVS doesnt have, said Migdalia Prater, a longtime Navarro Discount Pharmacy shopper. Opening a store here was the best idea. Prater said she would drive nearly a half hour south to Hialeah to shop at the Navarro store there once the former Pembroke Pines store closed. They have the best Spanish products that no one else has, she said. And the prices are always good. Each store sells pharmacy supplies, personal care and household products, limited grocery selections, some electronics and has a fragrance counter. Navarro Discount Pharmacy stores also offer photo processing services and sell cell phones from a select few major service providers. The pharmacy also sells its own private label brand called Vida Mia inside the Pembroke Pines store. Vida Mia product information is listed in English and Spanish on labels. View post: … Continue reading

Posted in Pharmacy | Comments Off on Navarro Discount Pharmacy opens in Pembroke Pines

CVS' New "Pharmacy Home" Plan

Posted: Published on March 8th, 2012

Recently, CVS Caremark (NYSE:CVS - News) along with Harvard University and Brigham and Women's Hospital, conducted an extensive research on health policy and came up with some new ways to save more money while being treated. Through the study, they pointed out the importance of a single pharmacy home for pharmacy customers. According to the research data, patients using a single pharmacy are more likely to connect with their own pharmacists on a regular basis. The researchers consider this twice as effective as taking prescribed medications and this will automatically reduce health care costs by thousands of dollars annually. This is more applicable to patients aging over 65 years who take two to three times more prescription medications than others. Around 10,000 people per day are expected to enter into the 65 years age group in the U.S. in the next 8 years. As a result, down the line, this pharmacy home concept of CVS is expected to gain more importance. CVS is gradually gearing up its performance in the field of Pharmacy Services. After a sluggish phase in fiscal 2010, the company exhibited improved performance in this segment throughout 2011 and has started off the 2012 selling season on … Continue reading

Posted in Pharmacy | Comments Off on CVS' New "Pharmacy Home" Plan

Fly research gives insight into human stem cell development and cancer

Posted: Published on March 8th, 2012

Public release date: 8-Mar-2012 [ | E-mail | Share ] Contact: Phyllis Edelman pedelman@genetics-gsa.org 301-351-0896 Genetics Society of America CHICAGO, IL March 8, 2012 Stem cells provide a recurring topic among the scientific presentations at the Genetics Society of America's 53rd Annual Drosophila Research Conference, March 7-11 at the Sheraton Chicago Hotel & Towers. Specifically, researchers are trying to determine how, within organs, cells specialize while stem cells maintain tissues and enable them to repair damage and respond to stress or aging. Four talks, one on Thursday morning and three on Sunday morning, present variations on this theme. For a fertilized egg to give rise to an organism made up of billions or trillions of cells, a precise program of cell divisions must unfold. Some divisions are "asymmetric": one of the two daughter cells specializes, yet the other retains the ability to divide. Chris Q. Doe, Ph.D., professor of biology at the University of Oregon, compares this asymmetric cell division to splitting a sundae so that only one half gets the cherry. The "cherries" in cells are the proteins and RNA molecules that make the two cells that descend from one cell different from each other. This collecting of different … Continue reading

Comments Off on Fly research gives insight into human stem cell development and cancer

Neuralstem Shows Solid Progress in Spinal Cord Neural Stem Cell Trial for ALS

Posted: Published on March 8th, 2012

MissionIR would like to highlight Neuralstem, Inc. (NYSE AMEX: CUR). The company's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. In addition to ALS, Neuralstem is also targeting major central nervous system conditions with its cell therapy platform, including spinal cord injury, ischemic spastic paraplegia, chronic stroke, and Huntington's disease. In the company's news yesterday, Neuralstem reported dosing of the fourteenth patient in its ongoing Phase I clinical trialing of the companys spinal cord neural stem cells in ALS (amyotrophic lateral sclerosis or Lou Gehrigs disease), marking the second patient to receive cells in the cervical (upper back) region of the spine and the trials first female patient. This is the first FDA-approved neural stem cell trial for the treatment of ALS. This treatment is designed to help remediate breathing function loss associated with progressive ALS, and the transplantation of stem cells observed in the trial will be keenly watched for safety/efficacy of spinal cord neural stem cells, as well as the intraspinal transplantation method. The first twelve patients … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Neuralstem Shows Solid Progress in Spinal Cord Neural Stem Cell Trial for ALS

Presentations at the Society of Toxicology Annual Meeting Demonstrate Superior Predictivity of Cellular Dynamics …

Posted: Published on March 8th, 2012

MADISON, Wis., March 8, 2012 /PRNewswire/ --Cellular Dynamics International, Inc. (CDI), the world's largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells for drug discovery and safety, today announced several customer presentations of studies employing the company's iCell products at the Society of Toxicology (SOT) Annual Meeting on March 11 to 15 in San Francisco. A number of these studies demonstrate the superior predictivity of CDI's human iPS cell-derived products compared to other cell models, such as animal models and immortalized cell lines, which are historically used in pharmaceutical drug discovery and toxicity testing. Customers will present 11 abstracts employing CDI's human cells in their research during the SOT meeting. Several of these compare the superior ability of CDI's iCell Cardiomyocytes and iCell Hepatocytes to predict toxic responses to currently available cell models. Among them: Puppala, D et al. (Abstract 420 Poster Board -642; Pfizer, Inc.) compared the ability of iCell Cardiomyocytes to a rat cardiac-derived cell line (H9C2) to predict the toxicity of 10 known in vivo cardiac toxins that were not flagged by the company's current in vitro assay systems. They found that iCell Cardiomyocytes showed increases in several toxicity signals and were … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Presentations at the Society of Toxicology Annual Meeting Demonstrate Superior Predictivity of Cellular Dynamics …

Nuvilex Points Toward Cell Encapsulation Technology Future to Expand Stem Cell Use for Late Stage Cancer Treatments

Posted: Published on March 8th, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)-- Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions, today discussed the potential use of the companys cell encapsulation technology with modified stem cells to treat late stage cancers. Stem cell therapy is not new to physicians dealing with blood and bone cancers, with stem cell transplants being an important treatment for growing new bone marrow since the 1970s. Recent studies have indicated the potential for using stem cells across a much broader range of cancers is becoming a reality, mostly a result of advances in cell and molecular biology techniques. Traditional chemotherapy works by targeting the fast-growing cells common to cancer tumors. Unfortunately, chemotherapeutics dont differentiate between healthy and cancerous cells. Patients suffering from metastatic cancers, where tumors have spread to multiple areas of the body, often have substantial difficulties with the chemotherapy needed to treat their disease. In one case, researchers at City of Hope and St. Jude Children's Research Hospital may have found a way to treat cancers that have spread throughout the body more effectively. They used genetically modified stem cells to activate chemotherapeutic drugs at the tumor sites, so that normal tissue surrounding the tumor and throughout … Continue reading

Comments Off on Nuvilex Points Toward Cell Encapsulation Technology Future to Expand Stem Cell Use for Late Stage Cancer Treatments

Stem cell repair kit for glaucoma could mean a treatment for the most common cause of blindness

Posted: Published on March 8th, 2012

By Fiona Macrae UPDATED: 02:37 EST, 8 March 2012 Important breakthrough: One in ten glaucoma sufferers go blind, due to late diagnosis, drugs not working or the disease being particularly severe (file picture) A treatment for one of the most common causes of blindness could soon be available. British researchers have used stem cells to heal the damage caused by glaucoma. The treatment has only been tested on rats, but scientists say it could be tested on humans by 2015 and in widespread use four years later. At present one in ten glaucoma sufferers go blind, due to late diagnosis, drugs not working or the disease being particularly severe. Researchers at University College London took healthy stem cells master cells capable of turning into other types of cell and widely seen as a repair kit for the body from human eyes. They used a cocktail of chemicals to turn them into retinal ganglion cells those that die in glaucoma. They then injected these into the eyes of rats with glaucoma-like damage. After just four weeks, the cells had connected with existing nerve cells, and the animals eyes worked 50 per cent better, the journal Stem Cells Translational Medicine reports. Researcher … Continue reading

Comments Off on Stem cell repair kit for glaucoma could mean a treatment for the most common cause of blindness

Fly research gives insight into human stem cell development and cancer

Posted: Published on March 8th, 2012

Public release date: 8-Mar-2012 [ | E-mail | Share ] Contact: Phyllis Edelman pedelman@genetics-gsa.org 301-351-0896 Genetics Society of America CHICAGO, IL March 8, 2012 Stem cells provide a recurring topic among the scientific presentations at the Genetics Society of America's 53rd Annual Drosophila Research Conference, March 7-11 at the Sheraton Chicago Hotel & Towers. Specifically, researchers are trying to determine how, within organs, cells specialize while stem cells maintain tissues and enable them to repair damage and respond to stress or aging. Four talks, one on Thursday morning and three on Sunday morning, present variations on this theme. For a fertilized egg to give rise to an organism made up of billions or trillions of cells, a precise program of cell divisions must unfold. Some divisions are "asymmetric": one of the two daughter cells specializes, yet the other retains the ability to divide. Chris Q. Doe, Ph.D., professor of biology at the University of Oregon, compares this asymmetric cell division to splitting a sundae so that only one half gets the cherry. The "cherries" in cells are the proteins and RNA molecules that make the two cells that descend from one cell different from each other. This collecting of different … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Fly research gives insight into human stem cell development and cancer

Nuvilex Points Toward Cell Encapsulation Technology Future to Expand Stem Cell Use for Late Stage Cancer Treatments

Posted: Published on March 8th, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)-- Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions, today discussed the potential use of the companys cell encapsulation technology with modified stem cells to treat late stage cancers. Stem cell therapy is not new to physicians dealing with blood and bone cancers, with stem cell transplants being an important treatment for growing new bone marrow since the 1970s. Recent studies have indicated the potential for using stem cells across a much broader range of cancers is becoming a reality, mostly a result of advances in cell and molecular biology techniques. Traditional chemotherapy works by targeting the fast-growing cells common to cancer tumors. Unfortunately, chemotherapeutics dont differentiate between healthy and cancerous cells. Patients suffering from metastatic cancers, where tumors have spread to multiple areas of the body, often have substantial difficulties with the chemotherapy needed to treat their disease. In one case, researchers at City of Hope and St. Jude Children's Research Hospital may have found a way to treat cancers that have spread throughout the body more effectively. They used genetically modified stem cells to activate chemotherapeutic drugs at the tumor sites, so that normal tissue surrounding the tumor and throughout … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Nuvilex Points Toward Cell Encapsulation Technology Future to Expand Stem Cell Use for Late Stage Cancer Treatments

Page 7,031«..1020..7,0307,0317,0327,033..7,0407,050..»